Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
In vitro evaluation of cytotoxicity of a naturally occurring cross-linking reagent for biological tissue fixation
1999
Cross-linking characteristics of biological tissues fixed with monofunctional or multifunctional epoxy compounds
1996
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Collagen/chitosan porous scaffolds with improved biostability for skin tissue engineering
2003 Standout
Ten-year experience with the porcine bioprosthetic valve: Interrelationship of valve survival and patient survival in 1,050 valve replacements
1990
Prosthetic Heart Valves
1996
Neuropathology of mitral valve prolapse in man and cardiopulmonary bypass (CPB) surgery in adolescent Yorkshire pigs
2000 StandoutNobel
Optimizing the tensile properties of polyvinyl alcohol hydrogel for the construction of a bioprosthetic heart valve stent
2002
Thrombotic and Bleeding Complications of Prosthetic Heart Valves
1987
Carpentier-Edwards Standard Porcine Bioprosthesis: Primary Tissue Failure (Structural Valve Deterioration) by Age Groups
1988
Adjustable tricuspid valve annuloplasty assisted by intraoperative transesophageal color Doppler echocardiography
1993
Device‐Associated Infections: A Macroproblem that Starts with Microadherence
2001 Standout
Conditional power for arbitrary survival curves to decide whether to extend a clinical trial
1991
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008
Chitosan-based hydrogels for controlled, localized drug delivery
2009 Standout
Anomalías congénitas de las arterias coronarias del adulto descritas en 31 años de estudios coronariográficos en el Principado de Asturias: principales características angiográficas y clínicas
2001
Heparin-Bonded Cardiopulmonary Bypass Circuits Reduce the Rate of Red Blood Cell Transfusion During Elective Coronary Artery Bypass Surgery
2005
High risk of thromboemboli early after bioprosthetic cardiac valve replacement
1995
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Exercise Standards for Testing and Training
2013 Standout
Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation
1999
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Decreased operative risk of surgical treatment of mitral regurgitation with or without coronary artery disease
1990
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
An overview of tissue and whole organ decellularization processes
2011 Standout
Mitral regurgitation
2009
Fifteen-Year Experience with 1678 Hancock Porcine Bioprosthetic Heart Valve Replacements
1989
Polymeric heart valves: new materials, emerging hopes
2009
Inhibition of the calcification of porcine valve tissue by selective lipid removal
1994
The Carpentier-Edwards pericardial aortic valve: Ten-year results
1995
Nanosilver as a new generation of nanoproduct in biomedical applications
2010 Standout
The effect of pathophysiology on the surgical treatment of ischemic mitral regurgitation: operative and late risks of repair versus replacement
1995
Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels
2015 Standout
A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease
2003 Standout
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
Aortic Valve Replacement with the Carpentier-Edwards Pericardial Bioprosthesis: Clinical and Hemodynamic Results
1988
Burden of valvular heart diseases: a population-based study
2006 Standout
A comparison of macroscopic lipid content within porcine pulmonary and aortic valves: Implications for bioprosthetic valves
1995
Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis
2001
Application of cell encapsulation for controlled delivery of biological therapeutics
2013
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
2008 Standout
Mid-Term Comparative Follow-Up After Aortic Valve Replacement with Carpentier-Edwards and Pericarbon Pericardial Prostheses
1999
The Carpentier-Edwards pericardial aortic valve: Intermediate results
1992
Twelve-Year Comparison of a Bjork–Shiley Mechanical Heart Valve with Porcine Bioprostheses
1991
Mitral valve reconstruction versus replacement for degenerative or ischemic mitral regurgitation
1994
Treatment of Infections Associated with Surgical Implants
2004 Standout
Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis
1988
The changing unnatural history of valvular regurgitation
1992
Lessons learned about the determinants of the results of valve surgery.
1988
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology
2006 Standout
Surgery of valve disease: late results and late complications
2001
Mitral valve replacement for mitral regurgitation with and without preservation of chordae tendineae
1984
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Open mitral commissurotomy
1980
Outcome of mitral valve repair in patients with preoperative atrial fibrillation
1994
Guías de práctica clínica de la Sociedad Española de Cardiología en valvulopatías
2000
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Surgery for Mitral Regurgitation
1988
Valve Repair Improves the Outcome of Surgery for Mitral Regurgitation
1995
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Sudden Death in Young Adults: A 25-Year Review of Autopsies in Military Recruits
2004 Standout
Chitosan—A versatile semi-synthetic polymer in biomedical applications
2011 Standout
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography
2003 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial.
2007
Durability of porcine valves at fifteen years in a representative North American patient population
1992
The Carpentier-Edwards standard porcine bioprosthesis
1990
Bioceramics
1998 Standout
Advanced functional polymer membranes
2006 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Prevention of Thromboembolism Using Aspirin after Mitral Valve Replacement with Porcine Bioprosthesis
1984
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Outcome of mitral valve repair in patients with preoperative atrial fibrillation. Should the maze procedure be combined with mitral valvuloplasty?
1994
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Intraoperative Doppler color flow mapping for decision-making in valve repair for mitral regurgitation. Technique and results in 100 patients.
1990
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices
1996
Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management
2012 Standout
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
2007
Works of Ignacio Gallo being referenced
Heparin-coated circuit in coronary surgery*A clinical study
1996
Incidence of Primary Tissue Valve Failure in Porcine Bioprosthetic Heart Valves
1988
A preliminary approach to the repair of myocardial infarction using adipose tissue-derived stem cells encapsulated in magnetic resonance-labelled alginate microspheres in a porcine model
2012
Comparative study of primary tissue failure between porcine (Hancock and Carpentier-Edwards) and bovine pericardial (Ionescu-Shiley) bioprostheses in the aortic position at five- to nine-year follow-up
1988
Conservative operation for mitral insufficiency
1980
Degenerative pathologic findings after long-term implantation of bovine pericardial bioprosthetic heart valves
1988
Comparative study of primary tissue valve failure between lonescu-shiley pericardial and Hancock porcine valves in the aortic position
1986
Clinical Experience with the Carpentier-Edwards Porcine Bioprosthesis: Short-term Results (from 2 to 4.5 Years)
1983
In vivo experimental assessment of polytetrafluoroethylene trileaflet heart valve prosthesis
1990
Five- to eight-year follow-up of patients with the Hancock cardiac bioprosthesis
1983
Late clinical results with the use of heterologous pericardium for closure of the pericardial cavity
1985
Degeneration in porcine bioprosthetic cardiac valves: Incidence of primary tissue failures among 938 bioprostheses at risk
1984
Incidence of primary tissue valve failure with the Ionescu-Shiley pericardial valve
1985
Four-to Seven-year Follow-up of Patients Undergoing Carpentier-Edwards Porcine Heart Valve Replacement
1985
Isolated mitral valve replacement with the hancock porcine bioprosthesis in rheumatic heart disease: Analysis of 213 operative survivors followed up 4.5 to 8.5 years
1984
The behavior of pericardial versus porcine valve xenografts in the growing sheep model
1987
Intraoperative Assessment of Mitral Valve Function
1978
Primary Tissue Valve Degeneration in Glutaraldehyde-Preserved Porcine Bioprostheses: Hancock I Versus Carpentier-Edwards at 4- to 7-Years' Follow-up
1986
Six- to ten-year follow-up of patients with the Hancock cardiac bioprosthesis
1986
Coronary arteriography and atrial thrombosis in mitral valve disease
1981